Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FEDRATINIB for Splenomegaly: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 11 adverse event reports in the FDA FAERS database where FEDRATINIB was used for Splenomegaly.

Most Reported Side Effects for FEDRATINIB

Side Effect Reports % Deaths Hosp.
Diarrhoea 143 10.2% 13 28
Death 138 9.8% 138 3
Nausea 114 8.1% 0 13
Fatigue 105 7.5% 0 10
Vomiting 74 5.3% 10 20
Constipation 59 4.2% 9 18
Platelet count decreased 48 3.4% 0 10
Asthenia 47 3.4% 2 14
Haemoglobin decreased 46 3.3% 1 12
Full blood count decreased 45 3.2% 0 14
Drug ineffective 42 3.0% 0 1
Anaemia 41 2.9% 1 11
Off label use 40 2.9% 7 6
Dizziness 37 2.6% 0 8
Illness 34 2.4% 1 6

Other Indications for FEDRATINIB

Myelofibrosis (682) Product used for unknown indication (307) Myeloproliferative neoplasm (146) Primary myelofibrosis (77) Polycythaemia vera (69) Off label use (56) Essential thrombocythaemia (28) Myelodysplastic syndrome (27) Hairy cell leukaemia (9) Thrombocytosis (8)

Other Drugs Used for Splenomegaly

RUXOLITINIB (270) JAKAFI (29) RITUXIMAB (27) BENDAMUSTINE (8) IBRUTINIB (8) PREDNISOLONE (6) HYDROXYUREA (5) PREDNISONE (5)

Related Pages

FEDRATINIB Full Profile All Splenomegaly Drugs FEDRATINIB Demographics FEDRATINIB Timeline